| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |